Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference
Summary
AnaptysBio announced that its CFO, Chris Murphy, will present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026. The company will webcast the presentation live from its investor relations site. AnaptysBio says it manages the financial collaborations for Jemperli with GSK and imsidolimab with Vanda. The company emphasizes that it focuses on protecting and returning royalty value to shareholders.
AskAI Classifications
Sectors
Fintech, Banking and Payments
FinTech Analytics
Functions
Accounting and Taxes
Data Management
Financial Reporting
Linked Companies
Vanda
up to $1M